Richard A. Meier - May 6, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 6, 2021
Transactions value $
$105
Form type
4
Date filed
5/7/2021, 07:48 PM
Next filing
May 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $397K +15K +17.79% $26.49 99.3K May 6, 2021 Direct
transaction BMRN Common Stock Sale -$397K -5.07K -5.1% $78.38 94.3K May 6, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15K -100% $0.00* 0 May 6, 2021 Common Stock 15K $26.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.405. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.